disease-free survival: endpoint for adjuvant therapy for cancer?
Published 1 year ago • 259 plays • Length 5:10Download video MP4
Download video MP3
Similar videos
-
50:38
adjuvant egfr tki therapy in patients with completely resected non-small-cell lung cancer: curren...
-
24:30
s1 episode 4: managing lung cancer with neoadjuvant and adjuvant therapy
-
27:11
optimizing adjuvant treatment of early breast cancer: where are we today?
-
6:13
include neoadjuvant chemotherapy for stage ii-iii lung cancer
-
2:44
disease-free survival in impower010 trial: adjuvant atezolizumab in nsclc
-
4:44
is disease-free survival a meaningful endpoint in nsclc? - medpage today
-
17:53
why do i need adjuvant therapy? communicating the risks for hr-positive, her2-negative ebc at hig...
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
2:19
checkmate 274: biomarkers linked to disease-free survival with adjuvant nivolumab
-
37:50
evolution of oncogenic-driven early-stage resectable nsclc: testing and practical considerations
-
7:53
improved progression-free survival with iressa as adjuvant therapy
-
11:11
lecture medical oncology - endpoints in clinical trials
-
3:41
disease free survival | radiotherapy edutech | common terms in oncology
-
1:31:34
tailoring targeted therapy: new directions for managing patients across the spectrum of nsclc
-
25:50
s3 episode 1: what are the latest improvements in targeted therapy options and diagnostic technol...
-
5:08
should adaura trial results change practice in nsclc?
-
36:48
outcome in mind: applying best practices for managing hr /her2- ebc at high risk of recurrence
-
8:55
studies back neoadjuvant strategies for melanoma